Measles virus spread initiated at international mass  gatherings in Europe, 2011 by Santibanez, Sabine et al.
1www.eurosurveillance.org
Research articles
Measles virus spread initiated at international mass 
gatherings in Europe, 2011
S Santibanez (SantibanezS@rki.de)1, K Prosenc2, D Lohr3, G Pfaff3, O Jordan Markocic4, A Mankertz1
1. National Reference Centre Measles, Mumps, Rubella and Regional Reference Laboratory WHO EURO, Division of Measles, 
Mumps, Rubella, and viruses affecting immunocompromised patients, Robert Koch Institute, Berlin, Germany
2. Laboratory for Virology, National Institute of Public Health of Slovenia, Ljubljana, Slovenia
3. Baden-Wuerttemberg State Health Office, District of Stuttgart Government, Stuttgart, Germany
4. Regional Institute of Public Health of Ljubljana, Slovenia
Citation style for this article: 
Santibanez S, Prosenc K, Lohr D, Pfaff G, Jordan O, Mankertz A. Measles virus spread initiated at international mass gatherings in Europe, 2011. Euro Surveill. 
2014;19(35):pii=20891. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20891 
Article submitted on 22 March 2013 / published on 04 September 2014
Three parallel transmission chains of measles virus 
(MV) variant ‘D8-Villupuram’ (D8-V) originated from 
two coinciding international mass gathering (MG) 
events in Rimini, Italy, in June 2011. MV D8-V was inde-
pendently introduced into Germany by two unvacci-
nated persons, and into Slovenia by one unvaccinated 
person who had attended these events. Secondary 
spread of D8-V was restricted to two generations 
of transmission in Slovenia as well as in Germany 
where the virus was further disseminated at another 
MG. Serological and epidemiological investigation 
of the D8-V-associated German and Slovenian cases 
revealed different antibody responses and age distri-
butions. Primary infected young persons between 11 
and 27 years-old were affected in Germany, whereas 
the group of Slovenian cases comprised adults aged 
from 28 to 47 years and a high proportion (9/14; 64%) 
of patients with secondary vaccine failure (SVF). Our 
study demonstrates that monitoring of MV transmis-
sion chains in an international context and adequate 
serological investigation of cases with remote vacci-
nation can contribute to identify susceptibility gaps.  
Introduction
The World Health Organization (WHO) European Region 
(EUR) has adopted the goal of eliminating endemic mea-
sles by 2015. In this region, a vaccine coverage of ≥95% 
with two doses of a measles containing vaccine (MCV) 
must be achieved and maintained in order to terminate 
endemic transmission of measles virus (MV) and reach 
a low annual incidence (<1 case per 1 million popula-
tion) [1]. However, the current measles situation in EUR 
is characterised by considerable differences in vaccine 
coverage and incidence across and within countries. 
Only a few countries report absence or sporadic occur-
rence of measles with a low annual incidence while oth-
ers observe resurgence of measles after a long period 
of low incidence (e.g. Slovenia) or are still experiencing 
outbreaks with hundreds or thousands of cases (e.g. 
Germany and Italy) [2]. In 2013, the majority of the EUR 
countries have reported an annual incidence of >1 case 
per one million population (http://data.euro.who.int/
cisid/?TabID=335279, data as 02 April 2014) indicating 
that the elimination target is not yet met. This situation 
implies the urgent need to uncover and analyse chains 
of MV transmission with the objective to identify vul-
nerable groups in the European population. 
Measles is an aerosol-borne and highly contagious viral 
disease characterised by fever and rash. The incuba-
tion period ranges from seven to 21 days from exposure 
to onset of fever and the rash usually appears about 14 
days after exposure [3]. A person infected with MV is 
highly infectious a few days before the rash appears. 
Contagious but not yet symptomatic individuals can 
deliver MV to others and may not be recognised as a 
source of infection. At mass gatherings (MGs), the high 
number of participants in a crowded setting can further 
increase the risk of MV transmission [4]. MV long-dis-
tance spread has repeatedly originated at international 
MGs by participants travelling back to their home coun-
try [5-7] and, as in our study, has even been transmit-
ted from one MG to the next. MGs therefore represent 
a test for countries approaching measles elimination. 
The present study investigates MV transmission chains 
that were initiated at two coinciding international MGs 
held in Rimini, Italy, in June 2011. We demonstrate that 
an adequate serological and molecular-epidemiological 
characterisation of cases linked to MGs may be helpful 
in tracing international MV transmission pathways and 
identifying unprotected population groups.
Methods
Clinical case definition
Measles cases that met the case definition of clini-
cal measles used by the WHO were included into this 
study: ‘Measles is an illness characterized by general-
ized maculopapular rash lasting 3 or more days with 
a temperature of 38.3°C (101°F) or higher, and cough, 
coryza, or conjunctivitis’ [8].
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Collection of clinical samples and case-based 
data
Measles is notifiable in Germany since 2001 [9] and in 
Slovenia since 1948 [10]. Laboratory confirmation of 
notified cases of suspected measles is performed by 
the WHO measles/rubella national reference laborato-
ries (NRLs) of Germany and Slovenia. The NRLs send 
sample collection devices with instructions and a labo-
ratory submission form to local public health authori-
ties, paediatricians and general practitioners as well 
as hospitals. The form collects the patients’ identifier, 
date of birth, sex and age, and asks whether the case 
definition is met. Furthermore, data on specimen col-
lection, onset of rash, complications, immunisation 
status, attendance of community institutions (e.g. kin-
dergartens, schools or hospitals), travel anamnesis, 
attendance at MGs and whether an epidemiological link 
to another case is known are requested by the form. 
The form is filled out by the ambulatory physician or by 
a medical doctor of the local public health institution. 
Additional epidemiological information is provided by 
the local public health institution via electronic mail or 
telephone. The case-based data are deposited in the 
databases of the NRLs.
Collection of data on immunisation status
Data from the immunisation certificate were entered 
into the laboratory request form by the treating phy-
sician (number of doses, dates of vaccination). If the 
immunisation certificate was not available, the vac-
cination status was either classified as ‘unknown’ or 
as ‘vaccinated in accordance to the schedule of man-
datory measles vaccination’ (Slovenia). In Slovenia, a 
MCV was offered first to children born in 1960 and 1961 
and became mandatory for unprotected children born 
since 1962 at school entry. Children born from 1968 
onwards have been vaccinated at eight months of age 
and children born since 1969 received a second dose 
at the age of five years. Since then, mandatory vacci-
nation with two doses of a MCV has been applied. The 
combined measles, mumps, rubella vaccine (MMR) is 
given to children born since 1989. In other republics of 
the former Yugoslavia, introduction of routine measles 
vaccination started later than in Slovenia. In the former 
German Democratic Republic, vaccination with a MCV 
was mandatory since 1970 with one dose and since 
1986 with two doses. In the former Federal Republic 
of Germany, one dose was recommended since 1974. 
In 1991, a nationwide two-dose MCV schedule with 
voluntary application was adopted in Germany; since 
2001, the first dose has been recommended at 11 to 14 
months and the second dose at 15 to 23 months [11].
Laboratory confirmation of suspected cases
Suspected clinical cases of measles were laboratory 
confirmed by detection of MV RNA and/or MV-specific 
IgM antibodies.
Serological investigation and classification of 
cases
MV-specific IgM and IgG antibodies in serum were 
determined by enzyme-linked immunosorbent assay 
(ELISA) (EUROIMMUN AG, Luebeck, Germany). To dis-
criminate between primary infection and secondary 
infection (reinfection), the IgG avidity index (AI) was 
determined in cases with MV RNA detection, by IgG 
Avidity ELISA (EUROIMMUN AG, Luebeck, Germany). A 
low AI (<20%) indicates a primary infection and a high 
AI (≥60%) a reinfection. A reinfection in a patient with a 
remote history of vaccination (>6 weeks) is referred to 
as secondary vaccine failure (SVF). For cases exhibiting 
intermediate AI values (≥20% and <60%), case classifi-
cation considered the interval between onset of symp-
toms and collection of serum.
Detection and genetic identification of measles 
virus
Genetic identification of MV detected in throat swab 
(TS) samples was performed by sequencing the 450 nt 
coding for the carboxy-terminal 150 amino acids of the 
nucleoprotein (N-450) and phylogenetic analysis [12,13] 
as recommended by the WHO [14]. Representative MV 
sequence data were submitted to the WHO Measles 
nucleotide surveillance (MeaNS) database [15] and to 
GenBank.
Criteria for case assignment
A measles case is considered infectious from five days 
before until four days after onset of rash. Successive 
measles cases are epidemiologically linked to each 
other when a subsequent case was in contact with an 
infectious case seven to 18 days before the onset of 
rash [16]. A case was assigned to an identified trans-
mission chain if it met one of the following criteria:
(i) Criterion 1: Case is infected with MV exhibiting 
sequence identity to that of the index case (MV variant 
D8-Villupuram ‘D8-V’) and the case is epidemiologi-
cally linked (directly or via a chain of successive cases) 
to the index case.
(ii) Criterion 2: Case without MV genotype information 
that has been laboratory-confirmed or not laboratory 
investigated is epidemiologically linked directly to the 
index case or a case that meets criterion 1.
Results
Pathways of measles virus transmission
The 16th Italia Super Cup, an international youth 
football tournament, was held close to Rimini, Italy, 
between 2 and 5 June 2011. Two German participants 
showed measles symptoms after returning to their 
place of residence in town A, German federal state of 
Baden-Wuerttemberg, on 15 and 17 June (week 24). The 
time span until onset of disease suggests that both 
cases may have contracted the virus during the football 
tournament (Table, Figure 1). The first case (16 year-old, 
unvaccinated) spread the infection to two unvaccinated 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































fell ill while he attended a music festival with 50,000 
visitors (‘Southside Festival’) in Neuhausen ob Eck 
(Baden-Wuerttemberg) between 17 and 19 June, 2011. 
Seven participants of this festival developed symp-
toms of measles between 25 and 30 June (weeks 25 
and 26). One of them passed the infection on to two 
relatives who showed measles symptoms on 4 and 8 
July (week 27).
The outbreak investigation performed by the public 
health authorities revealed two transmission chains 
with a total of 13 epidemiologically linked cases in 
Baden-Wuerttemberg (Figure 2). The presumed epi-
demiological link between the Baden-Wuerttemberg 
cases was confirmed by detecting the identical MV 
variant (MVi/Villupuram.IND/03.07) in the two index 
cases, three of nine secondary cases and one of two 
tertiary cases. This variant was first identified in 2007 
in Villupuram, India. Since it is a predominant variant, 
MVi/Villupuram.IND/03.07 is one of the few ‘named 
strains’ in the Measles Nucleotide Surveillance (MeaNS) 
database (GenBank accession number: FJ765078) and 
referred to as ‘D8-Villupuram’ (D8-V).
Another international sport event, the World Association 
of Kickboxing Organizations (WAKO) Bestfighter World 
Cup Tournament with 2,100 visitors was held in Rimini 
at the same time (3–5 June 2011). An unvaccinated 34 
year-old woman born in the former Yugoslav Republic 
of Macedonia and residing near town H in Slovenia, had 
attended the event as a seminar participant. After her 
return to Slovenia, she developed symptoms of mea-
sles on 17 June (week 24); the time line suggests that 
she may have acquired the infection during her stay 
in Rimini (Table, Figure 1). Eleven contacts in Slovenia 
fell ill between 28 June and 4 July (weeks 26 and 27) 
(Figure 3). Eight of these cases occurred in town H, 
while three respectively occurred in different towns 
located at a distance varying between 24 km and 62 
km of town H. One of the town H cases infected his 
spouse who showed rash and fever on 13 July in (week 
28). MV variant D8-V was detected in the index case, 
nine of 11 secondary cases and the only tertiary case, 
indicating spread of the imported virus in Slovenia. 
Two D8-V associated cases occurred in town H on 29 
June (week 26) and 11 July (week 28), but contacts to 
the identified D8-V transmission chain have not been 
recognised (Figure 3).
Measles virus transmissions in healthcare and 
community institutions in Slovenia
The majority of transmissions of D8-V MV in Slovenia 
occurred in healthcare and community institutions. 
When the index case first presented at a community 
healthcare centre near town H on 15 June, she may 
have transmitted the virus to a person visiting this cen-
tre on the same day, who subsequently was among the 
secondary cases investigated. The index patient also 
transmitted the virus to a staff member of the kinder-
garten which her child frequented. Nine secondary 
cases were putatively infected in a medical centre in 
town H on 19 June. Among them were five staff mem-
bers (3 nurses and 2 facility managers), three patients 
waiting in the same corridor as the index case and a 
visitor of the clinic. The index case was not immedi-
ately recognised as a measles case and consequently 
not isolated for several hours.
Source of identified measles virus
MV variant D8-V has been continuously detected in 
India from 2007 onwards (MVs/Kalahandi.IND/04.08/2, 
GenBank accession number: EU812246; MVs/Dimapur.
IND/14.09, HM773267; MVi/Kasargod.IND/12.10, 
HM358877; MVs/Pune.IND/07.11, JQ083634). The virus 
has been repeatedly introduced into Europe, for exam-
ple by a German tourist from Baden-Wuerttemberg 
returning from India in February 2011 (MVs/Tuebingen.
DEU/08.11). Immediately before the international MGs 
in Rimini started, D8-V was detected in several prov-
inces of central and northern Italy (MVs/Perugia.
Figure 1
Long-distance spread and local distribution of cases 
of measles virus variant D8-Villupuram (D8-V) 
epidemiologically linked to mass gatherings in Rimini, 
Italy, June 2011 (n=28)
a  Criterion 1: case is infected with measles virus exhibiting 
sequence identity to variant D8-V and the case is 
epidemiologically linked (directly or via a chain of successive 
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Long-distance spread of MV variant D8-V
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ITA/15.11/3, MVs/Gubbio.ITA/16.11, MVs/Monza.
ITA/21.11, MVs/LAquila.ITA/22.11, F. Magurano, per-
sonal communication, March 2014, MeaNS database). 
Outside of Italy, D8-V was only sporadically observed 
at this time (MVs/Pforzheim.DEU/17.11; MVs/London.
GBR/18.11/2, MVs/Bristol.GBR/21.11, K.E. Brown, per-
sonal communication, March 2014, MeaNS database; 
MVs/Douai.FRA/22.11, F. Freymuth, J. Dina, personal 
communication, March 2014, MeaNS database). A 
D8-V-associated case not linked to the MGs mentioned 
above was detected in week 16 2011 in Freiburg, Baden-
Wuerttemberg (MVs/Freiburg.DEU.26.11), when a child 
had contact to a case who had acquired the infection in 
Rome, Italy. In summary, these data indicate that D8-V 
was a contemporary virus in Italy in spring 2011.
Case classification
MV-serology was used to classify cases with evidence 
of MV shedding (MV RNA detection positive) either as 
primary infection or reinfection. Previously vaccinated 
cases with evidence of reinfection were classified as 
SVF.
Cases in Germany
Of the 13 measles cases in Baden-Wuerttemberg, 
serological test results were obtained for 10 (Table). 
Of these 10, three unvaccinated cases (cases 1.1, 2.7 
and 2.8) and one case with unknown vaccination sta-
tus (case 2.1) were IgM positive and exhibited a low AI. 
Another unvaccinated case (case 2.10) was negative 
for IgM and IgG. These data show primary infection in 
all (5/5) classified cases in Baden-Wuerttemberg. The 
remaining five cases were confirmed by a positive IgM 
in an external laboratory and could not be classified 
(cases 2.2, 2.3, 2.4, 2.5 and 2.6).
Cases in Slovenia
Fourteen of 15 laboratory-confirmed cases were clas-
sified by serology (Table). Of these 14 cases, 12 were 
confirmed by epidemiological link to belong to the 
transmission chain ‘Rimini-Slovenia’ whereas two were 
Figure 2
Chains of transmission of measles virus variant D8-Villupuram (D8-V) identified in Baden-Wuerttemberg, Germany, June–
July 2011 (n=13 cases)
Week in 201124 2625 2827
2.7 town A 
M, 20 y.
2.6 town E 
M, 20 y.
2.8 town F 
M, 24 y.
2.10 town G 
M, 11 y.
Case meets assignment criterion 1 (MV variant D8 -V detected, link to index case 1.1 or 2.1 epidemiologically confirmed)
Case meets assignment criterion 2 (link to index case 1.1 or 2.1 epidemiologically confirmed, MV genotype not determined)
1.2 town A 
M, 19 y.
2.4 town C 
M, 27 y.
2.2 town B 
F, 18 y.
2.5 town D 
M, 23 y.
2.3 town A 
F, 21 y.
2.9 town A 
F, 15 y.
1.3 town A 
F, 14 y.
2.1 town A 
M, 18 y.       
Index case
Transmission chain ‘Rimini -Baden-Wuerttemberg -1‘
Transmission chain ‘Rimini -Baden-
Wuerttemberg -2‘
1.1 town A 
M, 16 y.                  
Index case
F: female; M: male; MV: measles virus; y: years (age of cases is given in years).
The week given for each case refers to the date of onset of illness.
Towns B, C, D, E, F and G were at a distance of town A varying between 35 and 165 km. 
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assigned putatively by molecular evidence (cases 4 
and 5). Four of the five unvaccinated cases were IgM 
positive with negative or borderline IgG values (cases 
3.1, 3.9, 3.3 and 5) and one case was negative for IgM 
and IgG (case 3.2); indicating a primary infection. One 
case with two documented doses of a MCV (case 3.12) 
exhibited a positive IgM and an intermediate AI and was 
classified as a probable SVF. A second case with two 
documented vaccine doses (case 3.13) had a positive 
IgM and a high AI indicating a SVF. Seven cases could 
not provide documentation of vaccination. According to 
the Slovenian vaccination schedule, these individuals 
should have received one dose (cases 3.5, 3.7 and 4) or 
two doses of a MCV (cases 3.4, 3.8, 3.10 and 3.11). All 
had a high AI and were therefore also classified as SVF. 
Among them were two IgM positive (cases 3.7 and 4) 
and five IgM negative cases (cases 3.4, 3.8, 3.5, 3.10 
and 3.11). Overall, 5/14 (36%) primary infected cases, 
8/14 (57%) cases with a SVF and one case (7%) with a 
probable SVF have been observed in Slovenia. The SVF 




The 13 cases assigned to the two transmission chains 
in Baden-Wuerttemberg were 11 to 27 years-old and 
included one child (<14 years-old), three adolescents 
(>14 and <18 years-old) and nine young adults (>18 and 
<28 years-old). Overall the median age of the German 
cases was 19 years and the arithmetic mean 18.9 years.
Cases in Slovenia
The 13 cases assigned to the transmission chain in 
Slovenia and the two putatively associated cases were 
Figure 3
Chain of transmission of measles virus variant D8-Villupuram (D8-V) identified in Slovenia, June–July 2011 (n=15 cases)
M: male, F: female; y: years (age of cases is given in years).
The week given for each case refers to the date of onset of illness or sample collection (cases 3.11 and 3.12).
Towns I, J and K were at a distance of town H varying between 24 km and 62 km.
3.2 , town I
M, 34 y.
3.4 , town H, 
M, 30 y.
3.3 , town J 
M, 33 y.
3.5 , town H,
F, 46 y.
3.6 , town H, 
F, 28 y.
3.7 , town H,
F, 42 y.
3.9 , town H,
F, 47 y.
3.11 , town H,
M, 33 y.
3.8 , town K, 
M, 36 y.
3.10 , town H,
M, 35 y.
3.13 , town H,
F, 33 y.
Week in 201124 2625 2827




Case meets assignment criterion 1 (MV variant D8 -V detected, link to index case 3.1 epidemiologically confirmed)
Case meets assignment criterion 2 (link to index case 3.1 epidemiologically confirmed, MV genotype not determined)
MV variant D8 -V detected, link to index case 3.1 not epidemiologically confirmed  
4 , town H,    
F, 44 y.
5 , town H,      
M, 35 y.
3.1, town H, 
F, 34 y.
Index case                       
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adults aged from 28 to 47 years. A median of 34 years 
and an arithmetic mean of 36.1 years were calculated. 
The cases classified as primary infection (n=5) were 
33 to 47 years-old (median: 34 years, arithmetic mean: 
36.6 years), and the cases of SVF (n=8) or probable SVF 
(n=1) were 30 to 46 years-old (median: 35 years, arith-
metic mean: 36.8 years); the unclassified case was 28 
years-old.
Discussion
A molecular-epidemiological analysis enabled us to 
trace the spread of MV D8-V in Europe disseminated via 
three international MGs (Figure 1). Two of the MGs were 
held in Rimini, Italy, the third was held in Germany. 
Measles spread in the German MG via a case epide-
miologically linked to one of the Italian events. In 2011, 
indigenous MV transmission and a high measles inci-
dence (85.4 cases per 1 million population) had been 
documented in Italy where measles is notifiable and 
vaccination with two doses of a MCV is recommended 
[17,18]. In comparison, measles incidences in Germany 
and Slovenia were 19.5 and 10.8 cases per one mil-
lion population respectively [17]. D8-V was frequently 
detected in central and northern Italy immediately 
before the MG in Rimini started (F. Magurano, per-
sonal communication, March 2014). This finding sug-
gests that dissemination of MV D8-V to Germany and 
Slovenia was linked to a source in Italy and stresses 
the high risk of measles exposure at MGs in a country 
with high measles incidence.
Two transmission chains in Germany and one in 
Slovenia were initiated by unvaccinated participants 
(Figures 2 and 3). Transmission of the imported D8-V 
in Germany resulted in two chains with a total of 13 
identified cases that occurred in the Federal State of 
Baden-Wuerttemberg. The first German index case 
initiated only one generation of familial MV transmis-
sion (two cases); the second disseminated the virus at 
a music festival in Baden-Wuerttemberg with 50,000 
participants, initiating two generations of virus trans-
mission apparently restricted to Baden-Wuerttemberg. 
The chain in Slovenia comprised two generations of 
virus transmission with 13 assigned cases plus two 
putative cases.
Multiple transmissions of D8-V indicate that pockets 
of susceptible persons persist in Germany as well as 
in Slovenia. In Germany, the immunisation coverage 
increased from 2000 to 2010 for the first dose from 
91.1% to 96.4% and for the second dose from 19.4% 
to 91.5% [19]. In contrast, in Slovenia where vaccina-
tion with two doses of a MCV has been mandatory for 
children born since 1969, >95% coverage for the sec-
ond dose has been sustained since 1983 [10]. Slovenia 
had reported absence of measles cases from 2000 to 
2009, and a low incidence of one case per one million 
population in 2010 [10], whereas Germany had con-
tinuously experienced an annual incidence of >1 case 
per one million population [2,20]. The resurgence of 
measles in Slovenia demonstrates that absence of 
indigenous transmission over a long period cannot be 
equated with the absence of pockets of susceptibles 
in the population. The short circulation period of <6 
weeks for the imported D8-V suggests that the propor-
tion of susceptibles in the Slovenian as well as in the 
German population was not high enough to allow sus-
tained transmission.
Twelve of the 13 German cases were unvaccinated and 
11 to 27 years-old, adding evidence to a lack of protec-
tion in this age group [6,9,11]. In contrast, older indi-
viduals aged 28 to 47 years were affected in Slovenia. 
Moreover, there was no age difference between the 
unvaccinated primary infected Slovenian cases (n=5; 
mean age: 36.6 years, median age: 34 years) and the 
SVF cases (n=9; mean age: 36.8 years, median age: 
35 years). Two previous Slovenian cases associated 
with other MV genotypes (B3 and D4, data not shown) 
were of the same age group, indicating that the older 
age of the Slovenian cases was not particular for the 
transmission chain of D8-V. Recent outbreaks in the 
EUR were characterised by lower median ages, e.g. of 
11 years for the epidemic in Switzerland between 2006 
and 2009 and of 13.5 years in Bulgaria between 2009 
and 2011 [13,21]. The unusual high age of the cases in 
Slovenia may be due to absence of measles for a dec-
ade and the resulting shift of the susceptibles to higher 
age groups.
The proportion of SVF among the Slovenian cases was 
remarkably high (9/14; 64%). Case reports of SVF, 
i.e. measles infection in individuals with a previously 
documented seroconversion after MCV vaccination, are 
considered rare [22]. However, several reports describe 
a significant proportion of SVF in populations with sus-
tained high vaccination coverage [23-25] after long 
absence of MV transmission with the resultant lack of 
natural boosting, and waning of both the concentration 
as well as the avidity of anti-measles IgG antibodies 
[26]. Since the vaccination coverage in Slovenia has 
been continuously high over a long period, waned 
immunity may explain the high proportion of SVF. In 
case of SVF, MV replicates in presence of pre-existing 
vaccine induced neutralising antibodies. Viral replica-
tion and transmission is therefore limited and spread of 
MV occurs rarely, if at all [27]. The transmission chain 
in Slovenia showed two successive SVF cases within 
a family, indicating that a symptomatic SVF case can 
contribute to MV transmission. Our observation may 
serve as an incentive to monitor SVF more carefully, 
since the risk of emerging vaccine-escape variants is 
enhanced in such a setting due to exposure of virus to 
vaccine induced neutralising antibodies.
In Slovenia, MV D8-V was transmitted nosocomially in 
healthcare institutions (six infected healthcare work-
ers, HCWs) or in community facilities. Only one 47 
year-old HCW showed a primary infection that could 
have been prevented by a prior vaccination. This case 
demonstrates the need of providing evidence of pro-
tection by documentation of two doses of a MCV and/
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or a positive MV-specific IgG for all HCWs regardless 
of their year of birth. The five other cases occurred 
among previously vaccinated HCWs due to SVF. None of 
the infected HCWs caused a further nosocomial trans-
mission, which might be explained by a reduced viral 
shedding in case of SVF. Measles among both unvac-
cinated and vaccinated HCWs has also been reported 
from recent epidemics in Europe [28,29], but the role 
of SVF has rarely been investigated [30].
Our study highlights the high risk of contracting MV at 
international MGs in Europe and shows that MV D8-V 
has spread from Italy to Germany and Slovenia with 
subsequent local transmission. The restricted length 
of the identified local chains to two generations of 
transmission suggests that the immunisation cover-
age in the affected regions was high enough to prevent 
sustained MV transmission. We identified once more 
unvaccinated adolescents and young adults as a vul-
nerable group in Germany [31], whereas transmission 
of D8-V in Slovenia was observed in young and middle 
aged adults, most of whom were vaccinated (10 cases 
of 15). The finding of a high proportion of SVF (9/14; 
64%) among the Slovenian cases emphasises the 
necessity of laboratory-based case investigation as 
well as studies assessing population immunity in coun-
tries with long absence of MV circulation like Slovenia. 
In highly vaccinated populations, suspected measles 
infection in patients with a remote history of vaccina-
tion should be investigated by viral RNA detection, 
IgM, IgG and IgG avidity testing to uncover vaccine fail-
ure. SVF and its contribution to measles transmission 
should be surveyed closely. Participants of MG should 
check their vaccination status and those who cannot 
provide evidence of protection should receive at least 
one dose of MMR vaccine. This measure could help to 
close the immunisation gaps among adolescents and 
young adults in the EUR. 
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